REQUEST A DEMO
Total
USD $0.00
Search more companies

Taho Pharmaceuticals Ltd. (泰合生技药品股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Taho Pharmaceuticals Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Taho Pharmaceuticals Ltd. (泰合生技药品股份有限公司) is an enterprise in Taiwan, China, with the main office in Taipei City. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was established on April 01, 2026. Taho Pharmaceuticals Ltd. (泰合生技药品股份有限公司) currently employs 35 (2013) people. Its’ total assets recorded a growth of 72.29%.

Headquarters
3F, No.550, Ruiguang Road
Taipei City; Taipei City;

Contact Details: Purchase the Taho Pharmaceuticals Ltd. (泰合生技药品股份有限公司) report to view the information.

Website: http://www.tahopharma.com

Basic Information
Total Employees:
Purchase the Taho Pharmaceuticals Ltd. (泰合生技药品股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Taho Pharmaceuticals Ltd. (泰合生技药品股份有限公司) report to view the information.
Financial Auditors:
Purchase the Taho Pharmaceuticals Ltd. (泰合生技药品股份有限公司) report to view the information.
Incorporation Date:
April 01, 2026
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
7.41%
Purchase this report to view the information.
6.58%
Purchase this report to view the information.
3.61%
Purchase this report to view the information.
2.4%
Purchase this report to view the information.
2.38%
Company Performance
Financial values in the chart are available after Taho Pharmaceuticals Ltd. (泰合生技药品股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Total Operating Revenue
6537.82%
Operating Profit
-1.84%
EBITDA
-0.5%
Net Profit/Loss for the Period
2.01%
Total Assets
72.29%
Total Equity
82.85%
Return on Equity (ROE)
13.97%
Debt / Equity
-4717%
Quick Ratio
17975.99%
Cash Ratio
-8.68%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?